305 related articles for article (PubMed ID: 36056540)
1. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
[TBL] [Abstract][Full Text] [Related]
2. The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
Kim K; Cho K; Song J; Rahmati M; Koyanagi A; Lee SW; Yon DK; Il Shin J; Smith L
J Med Virol; 2023 Feb; 95(2):e28522. PubMed ID: 36691933
[TBL] [Abstract][Full Text] [Related]
3. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
4. A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.
Thi Hong Nguyen N; Ou TY; Huy LD; Shih CL; Chang YM; Phan TP; Huang CC
Front Public Health; 2023; 11():1145138. PubMed ID: 37333556
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
[TBL] [Abstract][Full Text] [Related]
6. Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations.
Ryu B; Shin E; Kim DH; Lee H; Choi SY; Kim SS; Kim IH; Kim EJ; Lee S; Jeon J; Kwon D; Cho S
BMC Infect Dis; 2024 Jan; 24(1):1. PubMed ID: 38166696
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
[TBL] [Abstract][Full Text] [Related]
8. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
9. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
[TBL] [Abstract][Full Text] [Related]
10. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D; Mateo-Urdiales A; Sacco C; Riccardo F; Bella A; Ambrosio L; Lo Presti A; Di Martino A; Ceccarelli E; Del Manso M; Fabiani M; Stefanelli P; Pezzotti P; Palamara A;
Int J Infect Dis; 2023 Apr; 129():135-141. PubMed ID: 36708869
[TBL] [Abstract][Full Text] [Related]
12. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
[TBL] [Abstract][Full Text] [Related]
13. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
Front Public Health; 2022; 10():949594. PubMed ID: 36187650
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Choi JY; Lee YJ; Ko JH; Kim SH; Kim HJ; Lee HW; Jeong H; Kim TY; Jang YG; Hong HJ; Kim MS; Lee SE; Kim YG; Chung EJ; Lim H; Jang S; Kim K; Kim SS; Ahn JY; Choi JY; Kim YC; Park YS; Peck KR; Kim B
Front Cell Infect Microbiol; 2022; 12():948014. PubMed ID: 35899050
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
Castelli JM; Rearte A; Olszevicki S; Voto C; Del Valle Juarez M; Pesce M; Iovane AN; Paz M; Chaparro ME; Buyayisqui MP; Markiewicz MB; Landoni M; Giovacchini CM; Vizzotti C
BMJ; 2022 Nov; 379():e073070. PubMed ID: 36450402
[TBL] [Abstract][Full Text] [Related]
16. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
18. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
Front Immunol; 2022; 13():940562. PubMed ID: 36091023
[TBL] [Abstract][Full Text] [Related]
19. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
[TBL] [Abstract][Full Text] [Related]
20. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
